Citation List for SAOP Tools

CRASH score

Original article: Extermann, M., et al., Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer, 2012. 118(13): p. 3377-86.

Other citations

Comment: S. Cousin, Journal d’OncoGériatrie, 3(5), 2012, p.247.

Luciani A, B.A., Battisti N, Romanato G, Caldiera S, Bergamo F, Roma A, Zagonel V, Foa P, The assessment of chemotherapy risk in elderly cancer patients: Validation of the CRASH score in an Italian cohort. J Clin Oncol, 2015. 33(suppl): p. e20521. http://abstracts.asco.org/156/AbstView_156_150632.html

Fargeas, J., Penot A, Olivrie A, Picat M-A, Touati M, Signol N, Jaccard A, Bordessoule D., Crash score in the older French non-Hodgkin lymphoma receiving chemotherapy, first results. J Geriatr Oncol, 2014. 5(Suppl 2): p. S12-S13.

Fargeas JB, Signol N, Penot A, Abraham J, Olivrie A, Picat MA, Jaccard A, Bordessoule D.CRASH SCORE IN THE OLDER FRENCH NON HODGKIN LYMPHOMA RECEIVING CHEMOTHERAPY, FINAL RESULTS. J Geriatr Oncol, 2015. 6 (suppl 1): p. S62.

Calderon O, Rojas V, Fasce G, Carrasco M, Herrera M, Nervi B, Scheel F. ESTIMATING HEMATOLOGIC CHEMOTHERAPY RISK OF

TOXICITY IN ELDERLY TREATED PATIENTS IN CATHOLIC UNIVERSITY OF CHILE CANCER CENTER. J Geriatr Oncol, 2015. 6 (suppl 1): p. S75.

 

MAX2

Original articles:

Extermann, M., et al., MAX2--a convenient index to estimate the average per patient risk for chemotherapy toxicity; validation in ECOG trials. Eur J Cancer, 2004. 40(8): p. 1193-8.

Extermann, M., et al., Predictors of tolerance to chemotherapy in older cancer patients: a prospective pilot study. Eur J Cancer, 2002. 38(11): p. 1466-73.

Other citations:

Extermann, M., et al., Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer, 2012. 118(13): p. 3377-86.

Janssen-Heijnen, M.L., M. Extermann, and I.E. Boler, Can first cycle CBCs predict older patients at very low risk of neutropenia during further chemotherapy? Critical reviews in oncology/hematology, 2011. 79(1): p. 43-50.

Hoppe, S., et al., Functional decline in older patients with cancer receiving first-line chemotherapy. J Clin Oncol, 2013. 31(31): p. 3877-82.

http://jco.ascopubs.org/content/31/31/3877.full.pdf+html

Shin, D.Y., et al., Toxicities and functional consequences of systemic chemotherapy in elderly Korean patients with cancer: A prospective cohort study using Comprehensive Geriatric Assessment. Journal of Geriatric Oncology, 2012. 3(4): p. 359-367.

Extermann, M., R.R. Reich, and M. Sehovic, Chemotoxicity recurrence in older patients: Risk factors and effectiveness of preventive strategies-a prospective study. Cancer, 2015. 121(17): p. 2984-92.

 

SAOP2

Original article: Extermann, M., Evaluation of the Senior Cancer Patient: Comprehensive Geriatric Assessment and Screening Tools for the Elderly, in Handbook of Cancer in the Senior Patient, D. Schrijvers, Aapro M, Zakotnik B, Audisio R, van Halteren H, Hurria A., Editor. 2010, Informa Healthcare: New York, London. p. 13-21.

Other citations

Gretchen Kimmick1, Rebecca Shelby2, Jessica Robertson1, Bailey Maloney3, Claudia Meyer4, Ravi Kanesvaran5, and Heidi White6. Detecting geriatric needs in older breast cancer patients through use of a brief screener. Am Geriatr Soc Annual Meeting, May 15-17, 2015.

Meurer AM, Small B, Balducci L, Kish J, El-Rady R, Van Schaick J, Sehovic M, Brown T, Aikman J, Extermann M. CHANGES IN GERIATRIC ASSESSMENT SCORES IN OLDER CANCER PATIENTS OVER TIME. J Geriatr Oncol, 2015. 6 (suppl 1): p. S71.

 

Note: This list does not track citations for the CIRS-G